Skip to content

Application of esmketamine in multimodal analgesia in cesarean section

Application of esmketamine in multimodal analgesia in cesarean section

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054435
Enrollment
Unknown
Registered
2021-12-17
Start date
2021-12-31
Completion date
Unknown
Last updated
2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

caesarean section

Interventions

Experimental group:esketamine with Butorphanol

Sponsors

Shiyan People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20 to 40 years; 2. It is planned to perform cesarean section operation under combined spinal-epidural anesthesia; 3. Body mass index (BMI) 1825kg/?; 4. American standards association (ASA) grades I to II.

Exclusion criteria

Exclusion criteria: 1. Patients with heart, brain, lung, liver, kidney and other major organ diseases; 2. Those with severe physical illness, cognitive dysfunction, mental illness, and language and communication barriers; 3. History of allergy to local anesthetics and opioids; 4. Those who are addicted to alcohol and drugs; 5. Long-term use of sedatives, analgesics, and long-term alcoholism.

Design outcomes

Primary

MeasureTime frame
Pressing times of 24h analgesic pump;

Secondary

MeasureTime frame
Visual Analogue Scale Score;Ramsay Sedation score;Times of remedial analgesic treatment;Postoperative adverse reactions;

Countries

China

Contacts

Public ContactRan Ran

Shiyan People's Hospital

18671910918@163.com+86 18671910918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026